Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testing

V Cesaroni, F Blandini, S Cerri - Expert Opinion on Therapeutic …, 2022 - Taylor & Francis
Introduction Parkinson's disease (PD) is the second most common neurodegenerative
disease after Alzheimer's disease. PD patients exhibit a classic spectrum of motor …
被引用次数：9 相关文章

Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testing

V Cesaroni, F Blandini, S Cerri - Expert opinion on …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Parkinson's disease (PD) is the second most common neurodegenerative
disease after Alzheimer's disease. PD patients exhibit a classic spectrum of motor …

Dyskinesia and Parkinson's disease: animal model, drug targets and agents in preclinical testing.

V Cesaroni, F Blandini, S Cerri - Expert Opinion on Therapeutic …, 2022 - europepmc.org
Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease. PD patients exhibit a classic spectrum of motor symptoms, arising …